The Food and Drug Administration (FDA) has approved Viekira Pak (ombitasvir, paritaprevir, ritonavir with dasabuvir tablets; AbbVie) for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1 infection, including cirrhosis.
Smart wearable devices could help to save as many as 1.3 million lives by the year 2020, according to a report from Soreon Research.
Inhibiting an intestinal nuclear receptor using tempol and antibiotics appears to be a promising treatment for nonalcoholic fatty liver disease (NAFLD).
A survey in the New England Journal of Medicine has found that the United States ranks third out of 29 countries in patient satisfaction from treatment received at their last visit with a doctor, but 24th in patient trust of doctors overall.
Multimodal analgesia for postoperative pain may help to reduce opioid use and decrease opoid-associated adverse effects, but is there an opioid-sparing effect with use of intravenous (IV) acetaminophen?
The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.
The flu is starting to tighten its grip on much of the United States, but vaccination remains the most effective means to prevent influenza and its complications.
According to a new report, half of U.S. states are poorly prepared to prevent, detect, and respond to infectious disease outbreaks.
Difficulty standing on one leg may indicate that or microbleeds have already occurred, which means the risk for more serious strokes is high, according to new research.
Prostaglandin analogue eye drops significantly reduce the risk of vision loss in patients with glaucoma, reports a new study.